Insiders · Profile

WORBOYS PHILIP D

SVP, Research & Transl Science at Theravance Biopharma. Filing since 12 Sep 2018. CIK 0001668718

Company
Date
Role
Action
Shares
Amount
Of holding
9 Mar 2021
SVP, Research & Transl Science
Sold, plan not stated
8,829
$176.58K
2.5%
3 Dec 2020
SVP, Research & Transl Science
Sold, plan not stated
4,246
$76.43K
1.3%
20 Aug 2020
SVP, Research & Transl Science
Sold, plan not stated
17,103
$307.85K
4.9%
12 Sep 2018
SVP, Translational Science
Sold, plan not stated
6,393
$182.20K
3.7%
4 decisions on file.